Patents by Inventor Youhei Satou

Youhei Satou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190211050
    Abstract: The present invention provides an oligomer which efficiently enables to cause skipping of the 53rd exon in the human dystrophin gene. Also provided is a pharmaceutical composition which causes skipping of the 53rd exon in the human dystrophin gene with a high efficiency.
    Type: Application
    Filed: March 26, 2019
    Publication date: July 11, 2019
    Applicants: NIPPON SHINYAKU CO., LTD., NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
    Inventors: Naoki WATANABE, Youhei SATOU, Shin'ichi TAKEDA, Tetsuya NAGATA
  • Publication number: 20190211049
    Abstract: The present invention provides an oligomer which efficiently enables to cause skipping of the 53rd exon in the human dystrophin gene. Also provided is a pharmaceutical composition which causes skipping of the 53rd exon in the human dystrophin gene with a high efficiency.
    Type: Application
    Filed: March 20, 2019
    Publication date: July 11, 2019
    Applicants: NIPPON SHINYAKU CO., LTD., NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
    Inventors: Naoki WATANABE, Youhei SATOU, Shin'ichi TAKEDA, Tetsuya NAGATA
  • Patent number: 10329319
    Abstract: The present invention provides an oligomer which efficiently enables to cause skipping of the 53rd exon in the human dystrophin gene. Also provided is a pharmaceutical composition which causes skipping of the 53rd exon in the human dystrophin gene with a high efficiency.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: June 25, 2019
    Assignees: NIPPON SHINYAKU CO., LTD., NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
    Inventors: Naoki Watanabe, Youhei Satou, Shin'ichi Takeda, Tetsuya Nagata
  • Publication number: 20180179538
    Abstract: Provided is a drug that allows highly-efficient skipping of exon 51 in the human dystrophin gene. The present invention provides an antisense oligomer which enables exon 51 in the human dystrophin gene to be skipped.
    Type: Application
    Filed: February 22, 2018
    Publication date: June 28, 2018
    Applicants: NIPPON SHINYAKU CO., LTD., NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
    Inventors: Tatsushi Wakayama, Haruna Seo, Youhei Satou, Shin'ichi Takeda, Tetsuya Nagata
  • Patent number: 9988629
    Abstract: Provided is a drug that allows highly-efficient skipping of exon 51 in the human dystrophin gene. The present invention provides an antisense oligomer which enables exon 51 in the human dystrophin gene to be skipped.
    Type: Grant
    Filed: March 11, 2015
    Date of Patent: June 5, 2018
    Assignees: NIPPON SHINYAKU CO., LTD., NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
    Inventors: Tatsushi Wakayama, Haruna Seo, Youhei Satou, Shin'ichi Takeda, Tetsuya Nagata
  • Publication number: 20170320903
    Abstract: The present invention provides a pharmaceutical composition which causes skipping of the 53rd exon in the human dystrophin gene with a high efficiency. The present invention provides an oligomer which efficiently enables to cause skipping of the 53rd exon in the human dystrophin gene.
    Type: Application
    Filed: June 12, 2017
    Publication date: November 9, 2017
    Applicants: NIPPON SHINYAKU CO., LTD., NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
    Inventors: Naoki WATANABE, Youhei SATOU, Shin'ichi TAKEDA, Tetsuya NAGATA
  • Patent number: 9708361
    Abstract: The present invention provides an oligomer which efficiently enables to cause skipping of the 53rd exon in the human dystrophin gene. Also provided is a pharmaceutical composition which causes skipping of the 53rd exon in the human dystrophin gene with a high efficiency.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: July 18, 2017
    Assignees: NIPPON SHINYAKU CO., LTD., NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
    Inventors: Naoki Watanabe, Youhei Satou, Shin'ichi Takeda, Tetsuya Nagata
  • Publication number: 20170067048
    Abstract: Provided is a drug that allows highly-efficient skipping of exon 51 in the human dystrophin gene. The present invention provides an antisense oligomer which enables exon 51 in the human dystrophin gene to be skipped.
    Type: Application
    Filed: March 11, 2015
    Publication date: March 9, 2017
    Inventors: Tatsushi WAKAYAMA, Haruna SEO, Youhei SATOU, Shin'ichi TAKEDA, Tetsuya NAGATA
  • Patent number: 9079934
    Abstract: The present invention provides an oligomer which efficiently enables to cause skipping of the 53rd exon in the human dystrophin gene. Also provided is a pharmaceutical composition which causes skipping of the 53rd exon in the human dystrophin gene with a high efficiency.
    Type: Grant
    Filed: August 31, 2011
    Date of Patent: July 14, 2015
    Assignees: NIPPON SHINYAKU CO., LTD., NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
    Inventors: Naoki Watanabe, Youhei Satou, Shin'ichi Takeda, Tetsuya Nagata
  • Publication number: 20150166995
    Abstract: The present invention provides a pharmaceutical composition which causes skipping of the 53rd exon in the human dystrophin gene with a high efficiency. The present invention provides an oligomer which efficiently enables to cause skipping of the 53rd exon in the human dystrophin gene.
    Type: Application
    Filed: February 6, 2015
    Publication date: June 18, 2015
    Applicants: NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY, NIPPON SHINYAKU CO., LTD.
    Inventors: Naoki WATANABE, Youhei SATOU, Shin'ichi TAKEDA, Tetsuya NAGATA
  • Publication number: 20150138107
    Abstract: Provided is an electronic device having a position detection function, the electronic device being capable of reducing consumption of electric current without losing operability. A detected information output section (5) (i) temporarily retains first detected information selected from detected information in accordance with control of a timing control section, and (ii) sequentially outputs, at a second cycle which is larger than a first cycle, a detected information group having the first detected information and second detected information selected from the detected information other than the first detected information.
    Type: Application
    Filed: May 21, 2013
    Publication date: May 21, 2015
    Applicant: SHARP KABUSHIKI KAISHA
    Inventors: Kenichi Horiuchi, Youhei Satou
  • Publication number: 20140025318
    Abstract: A pressure guiding tube blockage diagnosing device includes a receiving portion that receives pressure data from a pressure detecting portion, a feature quantity calculating portion that partitions a time series of pressure data, received by the receiving portion, into a plurality of intervals, and calculates, for each interval, a feature quantity indicating the state of fluctuation of a pressure, a change rate calculating portion that performs, for each interval, a smoothing process on the feature quantities over a specific time interval up to that interval, and calculates, from the feature quantities that have been subjected to the smoothing process, a change rate, for each interval, indicating the change of state of blockage of a pressure guiding tube therein, and an evaluating portion that evaluates the state of blockage of the pressure guiding tube based on the change rate calculated by the change rate calculating portion.
    Type: Application
    Filed: July 18, 2013
    Publication date: January 23, 2014
    Applicant: AZBIL CORPORATION
    Inventors: Youhei SATOU, Tetsuya TABARU, Masato TANAKA
  • Publication number: 20140025317
    Abstract: A pressure guiding tube blockage diagnosing device includes a feature quantity calculating portion partitioning a time series of pressure data into intervals, and calculating, for each interval, a feature quantity indicating the state of pressure fluctuation, an indicator value calculating portion calculating, for each individual interval, an indicator value indicating a state of blockage of pressure guiding tubes, from the feature quantities for a given time interval up until that interval, a change rate calculating portion performing, for each interval, a smoothing process on the indicator values over a specific time interval up to that interval, and calculating, from the indicator values that have been subjected to the smoothing process, a change rate for the indicator values for each interval, and an evaluating portion evaluating the state of blockage of a pressure guiding tube based on a change rate of the indicator value calculated by the change rate calculating portion.
    Type: Application
    Filed: July 18, 2013
    Publication date: January 23, 2014
    Applicant: AZBIL CORPORATION
    Inventors: Youhei SATOU, Tetsuya TABARU, Masato TANAKA
  • Publication number: 20130211062
    Abstract: The present invention provides a pharmaceutical composition which causes skipping of the 53rd exon in the human dystrophin gene with a high efficiency. The present invention provides an oligomer which efficiently enables to cause skipping of the 53rd exon in the human dystrophin gene.
    Type: Application
    Filed: August 31, 2011
    Publication date: August 15, 2013
    Applicants: NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY, NIPPON SHINYAKU CO., LTD.
    Inventors: Naoki Watanabe, Youhei Satou, Shin'ichi Takeda, Tetsuya Nagata